title: [Inflammatory bowel disease - the past 50 years].
abstract: Since ancient times chronic inflammatory bowel diseases have been known as non-contagious colitis and remain as an unsolved enigma of internal medicine. In the past 50 years it became clear that the incidence is increasing, the cause is multifactorial genetics as well as environment and the intestinal immune reaction is directed against the intestinal microbiota and not tissue antigens. Based on groundbreaking genetic studies the focus has moved from adaptive to innate immunity and thus from autoimmunity to a barrier defect. This paradigm shift will have a major impact on therapies which are traditionally immunosuppressive and will be developed to improve the antibacterial mucosal barrier in the future.
authors.affiliation: Innere Medizin I, Robert Bosch Krankenhaus, Stuttgart. Eduard.Stange@rbk.de
authors.forename: E F
authors.initials: EF
authors.lastname: Stange
mesh_terms: D005762:Gastroenterology / Q000266:history*; D005858:Germany; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007166:Immunosuppressive Agents / Q000266:history* / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000266:history / Q000628:therapy*
chemical_list: D007166:Immunosuppressive Agents